Plain-English translation of NCT06590012 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a supplement called can help people with heart disease caused by atherosclerosis (clogged arteries). You would take either the medication or a placebo (a look-alike pill with no active ingredient) every day for 2 years while researchers track whether it reduces serious heart events and improves how your body handles cholesterol and inflammation.
Clogged arteries remain a leading cause of heart attacks and strokes, even when patients take standard medications. Researchers want to know if this medication can provide extra protection by slowing the buildup of plaque in your arteries and reducing dangerous inflammation.
You likely qualify if…
You likely don't qualify if…
You will take either or a placebo by mouth once daily for 24 months alongside your regular heart medications. You'll visit the clinic once per year for blood tests and health check-ups to track whether you've had any heart events and to measure changes in your cholesterol and inflammation levels. The researchers will compare your results to those of other participants to see if the medication works better than placebo.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Russia